Editorial Board
For all enquiries, please contact the editorial office: [email protected]
Editor-in-Chief:
Professor Stefan Agewall
Institute of Clinical Medicine, Oslo University, Oslo, Norway
https://orcid.org/0000-0002-6942-6312
Associate Editors:
Johann Auer - Anticoagulation, Atrial Fibrillation, Acute and chronic coronary syndrome, Antiplatelet Therapy, Lipid-lowering Drugs, Heart Failure
St. Josef Hospital Braunau, Austria and Medical University Graz, Austria
Professor Heinz Drexel - Lipids, Triglycerides, LDL/HDL, Diabetes, Obesity, Exercise
Vorarlberg Institute for Vascular Investigation & Treatment, Feldkirch, Austria
https://orcid.org/000-0002-4677-975
Felice Gragnano - Antithrombotic therapy, Bleeding risk, Acute coronary syndromes, Chronic coronary syndromes, Atrial fibrillation, Clinical trials
University of Campania "Luigi Vanvitelli", Caserta, Italy
https://orcid.org/0000-0002-6943-278X
Professor Christopher Granger - Acute coronary syndromes, atrial fibrillation, antithrombotic therapy, cardiac arrest, systems of care, risk assessment
Duke University, USA
Professor Koji Hasegawa - Prevention, biomarkers, cell biology
National Hospital Organization Kyoto Medical Center, Kyoto, Japan
Professor Basil Lewis - ACS, intervention
Lady Davis Hospital, Carmel Medical Center, Haifa, Israel
https://orcid.org/0000-0001-5604-6399
Professor Giuseppe Rosano - Regulatory medicine, heart failure, cardiovascular disease in the elderly and women, sarcopenia and cachexia, cardiovascular effect of sex hormones, hypertension, CHD, cardiac metabolism, vascular physiology, endothelial function and inflammation
St George's Hospitals NHS Trust University of London, UK
Professor Juan Tamargo - Cardiovascular pharmacology, cardiovascular drug safety
Universidad Complutense, Madrid, Spain
Dr Jeffrey Washam - Cardiovascular pharmacology, cardiovascular drug safety, antithrombotic medications, critical care medications including vasoactive medications, sedative agents and antiarrhythmic agents.
Duke University, Durham, USA
Jong-Chan Youn - Preventive Cardiology, Cardiomyopathies, Myocarditis, Heart Failure, Heart Transplantation, Cardio-Oncology, Cardiovascular Immunology
Seoul Saint Mary's Hospital, Republic of Korea
Guest Editor
Gregory Y. H. Lip - Atrial fibrillation, anticoagulation
Liverpool Centre for Cardiovascular Science, Liverpool, UK
https://orcid.org/0000-0002-7566-1626
Editorial Board:
Stephan Achenbach - Imaging, acute coronary syndromes
University of Erlangen, Germany
Angeles Alonso - EDA regulation
Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain
Jane Armitage - Statins, lipid lowering, diet and nutrition, cardiovascular epidemiology
Clinical Trial Service Unit (CTSU), University of Oxford, Oxford, UK
Dan Atar - Atrial fibrillation, AMI, Heart failure, myocardial function, Reperfusion injury
Oslo University Hospital, Oslo, Norway
C. Noel Bairey Merz - Ischemic heart disease, CVD in women, CVD prevention, cholesterol guidelines
Barbra Streisand Women's Heart Center, Cedars-Sinai Heart Institute, Los Angeles, USA
Jeroen J Bax - Clinical cardiology, heart failure, cardiac resynchronization therapy, imaging
Leiden University Medical Center, Leiden, The Netherlands
John Beltrame - Hypertension, ischemia
University of Adelaide, Adelaide, Australia
Deepak L. Bhatt - Preventive cardiology, acute coronary syndromes, advanced techniques in cardiac, cerebral, and peripheral intervention
Harvard Medical School, Boston, USA
https://orcid.org/0000-0002-1278-6245
Vera Bittner - Cardiovascular disease prevention, cardiac rehabilitation, epidemiology
University of Alabama at Birmingham, Alabama, USA
Eugene Braunwald - Acute coronary syndrome, heart failure
Bringham & Women's Hospital, Boston, USA
Alida LP Caforio - Myocarditis, cardiomyopathies, pericardial disease, heart transplantation, heart failure, cardiovascular immunology
University of Padova, Padova, Italy
https://orcid.org/0000-0002-4901-5655
John Camm - Atrial fibrillation
St George's University of London, London, UK
https://orcid.org/0000-0002-2536-2871
Claudio Ceconi - RAS inhibition, heart failure therapy, impact of multiple comorbidities, anti anginal therapy, clinical trials, CAD secondary prevention
University of Ferrara, Ferrara, Italy
Elisabetta Cerbai - Cardiovascular pharmacology & Pharmacotherapy, cardiomyopathies, cardiac arrhythmias and antiarrhythmic drugs
University of Florence, UNIFI, Florence, Italy
Robin Choudhury - Inflammation, lipids, imaging, atherosclerosis
Oxford University, Oxford, UK
Renata Cifkova - Hypertension, cardiovascular prevention, lipids/lipid-lowering drugs
Thomayer Teaching Hospital, Prague, CZ
Raffaele De Caterina - Atrial fibrillation, acute coronary syndromes
Ospedale SS. Annunziata, Chieti, Italy
https://orcid.org/0000-0003-1637-574X
Gheorghe-Andrei Dan - Arrhythmias; Heart Failure or Cholesterol Lowering Therapy
Colentina University Hospital, Bucharest, Romania
Geneviève Derumeaux - Myocardial Imaging (strain, tissue Doppler Imaging), cardioprotection, metabolic cardiomyopathy
Institut Mondor de Recherche Biomédicale, Paris, France
Dobromir Dobrev - Antiarrhythmic drugs, CV drugs
University Duisburg-Essen, Essen, Germany
Robert Doughty - Heart failure, ecco, hypertension
University of Auckland, Auckland, New Zealand
Morten Wang Fagerlund - Statistician
Oslo University, Oslo, Norway
https://orcid.org/0000-0003-4535-5043
Gerasimos Filippatos - Heart failure
Athens University Hospital, Athens, Greece
Wolfgang-Michael Franz - Stem cell, heart failure, anticoagulants, platelet inhibition, gene therapy
Ludwig-Maximilian-University, Munich, Germany
Keiichi Fukuda - Heart failure, hypertension, hyperlipidemia
Keio University School of Medicine, Tokyo, Japan
Christian Funck-Brentano - Antiarrhythmic drugs, drug pharmacokinetics and pharmacodynamics, QT interval prolongation, phase I/II/III clinical trials: design, methodology, drug metabolism, transport and interactions
Pitié-Salpêtrière University Hospital, Paris, France
https://orcid.org/0000-0003-0406-5189
Bernard Gersh - Cardiomyopathies, CAD
Mayo Clinic, Rochester, USA
Evangelos Giannitsis - Atrial fibrillation, ACS, thrombosis
University of Heidlberg, Heidlberg, Germany
Robert P Giugliano - ACS, anticoagulants
Brigham and Women's Hospital, Boston, US
Shinya Goto - Antiplatelet, anticoagulant
Tokai University School of Medicine, Tokyo, Japan
Stefan Hohnloser - Atrial fibrillation, anticagulantia
Klinikum der J. W. Goethe-Universtität, Frankfurt, Germany
Dayi Hu - Atherosclerosis, Epidemiology
People's Hospital of Peking University, Beijing, China
Stefan James - Intervention, antiplatelet, STEMI
Uppsala Clinical Research Center, Uppsala, Sweden
Juan Carlos Kaski - Management of angina pectoris, Management of risk factors for coronary artery disease, Statins and diabetes, Management of coronary artery spasm, Anti-inflammatory interventions in atherosclerosis
St George's University of London, London, UK
John J.P. Kastelein - Lipids, imaging, inflammation, diabetes, obesity
University of Amsterdam, Amsterdam, The Netherlands
Paulus Kirchhof - Atrial fibrillation, sudden death, cardiomyopathies, general cardiology, genomics
Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, UK
https://orcid.org/0000-0002-1881-0197
Sverre Kjeldsen - Hypertension
Ullevaal University Hospital, Oslo, Norway
Maddalena Lettino - Antithrombotic agents (anti platelet drugs, old and novel anticoagulants), acute coronary syndromes, pulmonary embolism, cardiac intensive care
Humanitas Research Hospital, Milano, Italy
A Michael Lincoff MD - antithrombotic, lipid lowering, and diabetic agents
Director, C5Research (Cleveland Clinic Coordinating Center for Clinical Research)
Director, Center for Clinical Research, Lerner Research Institute
Vice Chairman, Department of Cardiovascular Medicine, Heart and Vascular Institute
Professor of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
Cleveland Clinic, Cleveland, OH
Gregory Y. H. Lip - Atrial fibrillation, anticoagulation
Liverpool Centre for Cardiovascular Science, Liverpool, UK
https://orcid.org/0000-0002-7566-1626
Leonardo De Luca - Interventional cardiology, acute coronary syndrome, myocardial ischemia, cardiogenic shock, atrial fibrillation, preventive cardiology
Department of Cardiosciences, San Camillo-Forlanini, Rome, Italy
Jolanta Siller Matula - Antithrombotic drugs, interventional cardiology
Department of Cardiology, Medical University of Vienna, Vienna, Austria
Julinda Mehilli - Antithrombotics for interventionally treated coronary and structural heart disease, PCI of complex coronary artery disease including left main and chronic occlusion lesions, TAVI
Department of Internal Medicine I, University of Munich, Germany
Chiara Melloni - Acute coronary syndromes, antithrombotic drugs, clinical pharmacology, early drug development and drug safety, optimal CV treatment in patients with cardiovascular disease and concomitant cancer
Duke University School of Medicine, North Carolina, USA
https://orcid.org/0000-0002-6837-0177
Pasquale Mone - Frailty, aging, cardiometabolic diseases, heart failure, coronary artery disease, hypertension, diabetes, prediabetes, insulin resistance and cognitive impairment
University of Molise, Campobasso, Italy
Eliano Pio Navarese - Interventional cardiology, acute coronary syndrome, myocardial ischemia, diabetes, statins and cholesterol-lowering agents, design of clinical and randomized studies and advanced statistical analysis, evidence based medicine projects and meta-analysis
Heinrich-Heine-Universitat Dusseldorf, Dusseldorf, Germany
Alexander Niessner - Statistics of cardiovascular trials, critical review of cardiovascular clinical trials, cardiovascular risk factors and prevention of atherosclerotic diseases, biomarkers in cardiovascular diseases, anticoagulation
Medical University of Vienna, Vienna, Austria
Koichi Node - Myocardial Disease, Valvular Heart Disease
Saga University, Saga, Japan
Michelle L O'Donoghue MD - Clinical trials, Acute coronary syndromes, Antiplatelet therapy, Anticoagulant therapy
Senior Investigator, TIMI Study Group
Associate Professor of Medicine, Harvard Medical School Cardiovascular Division, Brigham and Women's Hospital, Boston, MA
Dr Koh Ono - Atherosclerosis, heart failure, microRNA, drug therapy, molecular biology
Kyoto University Graduate School of Medicine, Kyoto, Japan
Pasquale Perrone-Filardi - Prevention, imaging
University of Naples, Naples, Italy
Fausto Pinto - NOAC, CHD, cardiovascular Imaging
Lisbon Cardiovascular Institute, Lisbon, Portugal
Bertram Pitt - Heart failure, MRA
University of Michigan, Ann Arbor, USA
Silvia Priori - Arrhythmias, anti arrhythmic drugs, cellular electrophysiology, cardiomyopathies, cardiac arrest, QT interval, sudden death, genetics of arrhythmias, genetics of cardiomyopathies
Fondazione Salvatore Maugeri, University of Pavia, Pavia, Italy
Harmony Reynolds - Myocardial infarction, microvascular coronary artery disease, stable ischemic heart disease, heart disease in women, takotsubo cardiomyopathy
NYU Langone Medical Center, New York, USA
Bianca Rocca - Antiplatelet drugs and platelet pharmacology, eicosanoids, von Willebrand factor (primary haemostasis), cyclooxygenase inhibitors including NSAIDs, oral anticoagulants
Catholic University School of Medicine, Rome, Italy
Luis Ruilope - Hypertension, renal disease
Hospital 12 de Octubre, Madrid, Spain
https://orcid.org/0000-0001-6278-7951
Marc S. Sabatine - Antiplatelet, anticoagulants and pharmacogenetics
Brigham and Women's Hospital, Boston, USA
Raul Santos - Diabetes, atherosclerosis
University of Sao Paulo, Sao Paulo, Brazil
Gaetano Santulli - Hypertension, Aging, Diabetes, Vascular disease, Calcium handling, microRNA, Restenosis, Thrombosis, Sympathetic System, Metabolic syndrome, Endothelial function, Drug Eluting Stents, Mitochondria, Myocardial infarction, Heart failure, Cardiac Resynchronization Therapy, Atrial Fibrillation
Columbia University, New York, USA
Gianluigi Savarese - Heart failure; clinical trials; registries; epidemiology
Karolinska Institutet, Stockholm, Sweden
Irina Savelieva - Atrial fibrillation, arrhytmias, antiarrhythmic drugs, anticoagulation
St George's University of London, London, UK
Anne Grete Semb - Cardiovascular disease, risk and prevention of cardiovascular disease in patients with inflammatory rheumatic joint diseases, lipids, inflammation
Diakonhjemmet Hospital, Oslo, Norway
Abhinav Sharma - Cardiovascular Surgery (Heart Transplantation); Diabetes, Heart Failure
McGill University, Montreal, Canada
Gerasimos Siasos - Atherosclerosis, arterial stiffness, endothelium/endothelial function, vascular function
Brigham and Women's Hospital, Harvard Medical School, Boston, USA
https://orcid.org/0000-0001-7601-8870
Tabassome Simon - Pharmacogenetic of cardiovascular drugs, antiplatelet agents, ACS, hormone therapy in menopausal women, risk factors
Hôpitaux de Paris, Paris, France
Karen Sliwa-Hahnle -Heart failure
Hatter Institute for Cardiovascular Research in Africa, University of Cape Town, South Africa
Philippe Gabriel Steg - Antithrombotics, CAD
Hôpital Bichat - Claude-Bernard, Paris, France
https://orcid.org/0000-0001-6896-2941
Patrick Sulzgruber - Interventional cardiology, Anti-platelet Therapy, Anti-thrombotic Therapy, Clinical Cardiology, Heart failure, Biomarker Research, Epidemiology, Personalized Medicine, Digital Health
Medical University of Vienna, Vienna, Austria
https://orcid.org/0000-0001-5146-0099
Ta-Chen Su MD PhD - clinical lipidology, such as hyperlipidemia including severe hypertriglyceridemia (hyperchylomicronemia) and familial hypercholesterolemia
Director and Clinical Professor, Department of Environmental and Occupational Medicine
Clinical Professor, Department of Internal Medicine and Cardiovascular Center
National Taiwan University Hospital and National Taiwan University College of Medicine
Christian Torp Pedersen - Registry, arrhytmia
Aalborg University Hospital, Aalborg, Denmark
Hung-Fat Tse - Atrial fibrillation, arrhythmias
Univeristy of Hong Kong, Hong Kong
Wiek H van Gilst - Heart failure
University Medical Center Groningen, Groningen, The Netherlands
Jeff Washam, PharmD, FAHA- Pharmacology and Pharmacotherapy; Use of CV pharmacotherapies in patients with chronic kidney disease and Use of pharmacotherapies in cardiac ICU setting
Clinical Pharmacist
Cardiac Intensive Care Unit, Duke Heart Center Consulting Associate Department of Medicine, Duke University
Sven Wassmann - Intervention, anticoagulants and antiplatelets, atherosclerosis, CAD / ACS, stem cells
Isarklinikum, Munich, Germany
Phillip Weeks - anticoagulants, antiplatelet agents, heart failure guideline-directed medical therapy, transplant pharmacotherapy, drug-drug interaction
Memorial Hermann Texas Medical Center, Texas, USA
https://orcid.org/0000-0001-6437-849X
Harvey White - Antithrombotic treatment in ACS
Auckland City Hospital, Auckland, New Zealand
Petr Widimsky - ACS antiplatelet, anticoagulant, thrombolytic
Charles University, Prague, Czech Republic
https://orcid.org/0000-0001-5686-7752
Sun Yihong - Coronary artery disease, Atrial fibrillation, Prevention, Risk factor control
China-Japan Friendship Hospital, Beijing, China
José Luis Zamorano - Lipids, hypertension, imaging
University Hospital Ramón y Cajal, Seville, Spain
Faiez Zannad - Heart failure
Inserm-CHU, Nancy, France
Social Media Editors
Doreen Su-Yin Tan - cardiovascular pharmacotherapy, anti-thrombotics, pharmacogenomics
Department of Pharmacy, Faculty of Science, National University of Singapore
Cardiology Specialist Pharmacist, National University Hospital Heart Center, Singapore (NUHCS)
https://orcid.org/0000-0002-2090-2517
Mattia Galli - Antithrombotic drugs, atrial fibrillation, pharmacogenetics, interventional cardiology, acute coronary syndrome, myocardial ischemia, clinical and randomized studies, meta-analysis and advanced statistical analysis.
Catholic University of the Sacred Heart, Rome, Italy
https://orcid.org/0000-0003-3909-182X
Felice Gragnano - Antithrombotic therapy, Bleeding risk, Acute coronary syndromes, Chronic coronary syndromes, Atrial fibrillation, Clinical trials
University of Campania "Luigi Vanvitelli", Caserta, Italy
https://orcid.org/0000-0002-6943-278X
